Research and Development Active Pharmaceutical Ingredients Supply Chain Management Quality Assurance Quality Control Domestic Production Branded Drugs Regulatory Affairs Generic Drugs National Security Regulations Global Supply Chain Sterile Injectable Medicines Supply Chain Disruptions Plant Recovery Tariffs on Drugs Tariffs Ibrexafungerp Contamination Zero Gravity Manufacturing Regulatory Processes Supply Chain Issues Active Ingredients Regulatory Environment Synthesis Techniques Supply Chain Manufacturing Companies Pain Relief Acetaminophen Production Sustainable Practices Weight Management Medicine Production Good Manufacturing Practices Generic Medicines U.S. Production Global Market Economic Factors Biotechnology Regulatory Compliance Healthcare Innovation Pharmaceutical Companies Inspection Backlog Imports Product Development Chemical Safety Towa Pharmaceutical Eli Lilly Drug Pricing Corporate Investments in Healthcare Drug Shortages Supply Disruptions Production Facilities Damage
State incentives worth up to $105 million helped secure the site to boost U.S. capacity.
